Motif Bio Announces New Iclaprim Data being Presented at ECCMID 2018
Apr 19, 2018 06:00 am UTC| Business
NEW YORK, April 19, 2018 -- Positive efficacy and safety highlights from Phase 3 REVIVE-2 trial in ABSSSIPotential to avoid costs related to vancomycin-associated acute kidney injury in ABSSSIData continue to...
Nestlé reports three-month sales for 2018
Apr 19, 2018 05:18 am UTC| Business
This press release is also available in Français (pdf) and Deutsch (pdf) Follow today's event live14:00 CEST Investor call audio webcastFull details in Events ............. Vevey, April 19, 2018 Nestlé reports...
Apr 19, 2018 05:06 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 19 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
Apr 19, 2018 05:01 am UTC| Business
REGULATED INFORMATION GHENT, Belgium, 19 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major...
Heron’s Drilling Delivers Massive Sulphide Intercepts at G2 and Lisa Lenses
Apr 19, 2018 04:01 am UTC| Business
Sydney, New South Wales, April 19, 2018 -- Heron Resources Limited (ASX:HRR “Heron” or the “Company”) is pleased to advise that it has intersected significant base-metal sulphide mineralisation at its wholly-owned...
Algeco Scotsman Releases Fourth Quarter 2017 Financial Report
Apr 19, 2018 03:21 am UTC| Business
BALTIMORE, April 18, 2018 -- Algeco Investments B.V. (together with its subsidiaries, “Algeco Scotsman”), the leading global business services provider of modular space, secure portable storage solutions and remote...
Aeglea BioTherapeutics Prices Public Offering of Common Stock
Apr 19, 2018 02:50 am UTC| Business
AUSTIN, Texas, April 18, 2018 -- Aeglea BioTherapeutics, Inc., (Nasdaq:AGLE) a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases...